First American Bank acquired a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 61,022 shares of the financial services provider’s stock, valued at approximately $10,584,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Solstein Capital LLC acquired a new stake in shares of Marsh & McLennan Companies in the 4th quarter valued at about $25,000. SHP Wealth Management acquired a new position in shares of Marsh & McLennan Companies during the fourth quarter worth about $26,000. KERR FINANCIAL PLANNING Corp bought a new position in shares of Marsh & McLennan Companies during the fourth quarter worth about $27,000. Golden State Wealth Management LLC acquired a new stake in Marsh & McLennan Companies in the 4th quarter valued at approximately $27,000. Finally, Atlas Capital Advisors Inc. bought a new stake in Marsh & McLennan Companies in the 4th quarter valued at approximately $28,000. 87.99% of the stock is owned by institutional investors and hedge funds.
Marsh & McLennan Companies Stock Performance
Shares of MRSH opened at $166.10 on Thursday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. Marsh & McLennan Companies, Inc. has a 1-year low of $156.60 and a 1-year high of $219.71. The firm has a market cap of $80.24 billion, a P/E ratio of 20.76, a PEG ratio of 2.39 and a beta of 0.62.
Analyst Ratings Changes
Several equities analysts have recently weighed in on the stock. Mizuho decreased their price target on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research note on Monday, April 13th. JPMorgan Chase & Co. cut their price objective on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a research report on Thursday, April 9th. Barclays decreased their target price on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Citigroup upgraded shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price target on the stock in a research note on Wednesday, May 6th. Finally, Morgan Stanley reduced their price objective on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a research note on Monday, April 6th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $200.19.
Check Out Our Latest Stock Report on Marsh & McLennan Companies
Insider Transactions at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the transaction, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.38% of the company’s stock.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
